FindTrial
Sign In

patients undergoing with high and low uterine contraction frequency prior to embryo transfer

Use of Buscopan in patients undergoing IVF/ICSI treatment with high and low uterine contraction frequency prior to embryo transfer: A prospective double-blinded randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000033106
Enrollment
Unknown
Registered
2020-05-21
Start date
2020-06-01
Completion date
Unknown
Last updated
2020-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility

Interventions

Group A:1 ml 20mg Buscopan injection
Group B:1 ml normal saline injection

Sponsors

The Chinese University of Hong Kong
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Women undergoing embryo transfer in either fresh or frozen cycles

Exclusion criteria

Exclusion criteria: 1. Women aged > 42 years old; 2. Women with factors which will affect uterine contractility; 3. congenital uterine anomaly; 4. acquired uterine pathology such as myoma >5cm, adenomyosis >5cm or endometrial polyp; 5. Women with presence of hydrosalpinx; 6. Women undergoing pre-implantation genetic test in IVF cycles; 7. History of allergy to misprostol, Buscopan or same group of drug; 8. Contraindication to the use of Buscopan e.g. glaucoma, myasthenia gravis, tachycardia, megacolon; 9. Women who are on other smooth muscle relaxant other than Buscopan.

Design outcomes

Primary

MeasureTime frame
live birth rate;—

Secondary

MeasureTime frame
implantation rate;clinical pregnancy rate;miscarriage rate;—

Countries

China

Contacts

Public ContactMak Sze Man Jennifer

The Chinese University of Hong Kong

jennifermak@cuhk.edu.hk+852 35051764

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026